Drug intelligence / Profile preview

Bushenjiangzhi

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Bushenjiangzhi is a traditional Chinese medicine formula primarily used in the context of Traditional Chinese Medicine (TCM) for health management related to menopause and liver conditions such as hepatocellular carcinoma. It is considered a herbal or botanical formulation aimed at "tonifying the kidney and regulating" functions according to TCM principles. Clinical research has investigated its effects on survival in patients with moderate and advanced hepatocellular carcinoma, suggesting potential supportive benefits in cancer care. The exact pharmacological mechanism of action is not well defined in Western biomedical terms but may involve modulation of immune function, anti-inflammatory effects, or other systemic regulatory actions typical of multi-herb TCM formulas.

Other names: Bushen Jiangzhi formulaBushen Jianpi formula

Beyond the preview

Go deeper on Bushenjiangzhi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bushenjiangzhi.

Explore the full profile